Novartis hails digital strategy as profits hold up during pandemic -

pharmaphorum, 26/01/2021

Partagé par : 

Beesens TEAM

Novartis hails digital strategy as profits hold up during pandemic -

"Novartis has said that its investment in digital technology has helped it to ride out the worst of the pandemic, although sales of some of its newly-launched products have been affected by a fall in prescriptions and hospital visits.

The big Swiss pharma still managed to grow sales in Q4 compared with the same period last year, with sales increasing a reported 3% to $12.8 billion and profits growing 2% to just over $3 billion.

Under the leadership of CEO Vas Narasimhan, who took over in 2018, the company has focused on using digital technology to engage with both patients and doctors.

In a conference call outlining the company’s Q4 figures, Narasimhan and his leadership team said that this approach had helped overcome some of the challenges laid down by the pandemic.

However, the company did caution that its predictions for 2021 were based on an understanding that prescription drugs sales in hospitals would start to return to normal in the second half of the year...." Lire la suite